Catridecacog News
Catridecacog currently has 0 news articles, with 11 predicted indications.
This page combines the AI-predicted indications for Catridecacog with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Long-term prophylactic treatment of bleeding in adult and paediatric patients 6 years and above with congenital factor-XIII-A-subunit deficiency.
- Evidence level: L5
- Predicted indications (11):
- factor XIII, A subunit, deficiency (50.0%)
- primary release disorder of platelets (99.3%)
- pseudo-von Willebrand disease (99.3%)
- Glanzmann thrombasthenia (99.2%)
- congenital factor XIII deficiency (98.8%)
- hemophilia (98.3%)
- Scott syndrome (98.2%)
- acquired coagulation factor deficiency (97.8%)
- bleeding diathesis due to a collagen receptor defect (97.3%)
- hemorrhagic disorder due to a constitutional thrombocytopenia (97.3%)
- acquired hemophilia (97.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.